Hematological safety of hyperbaric oxygen therapy... (2025 study) Skip to main content
Retrospective Study Medicine (Baltimore) 2025

Hematological safety of hyperbaric oxygen therapy in oncology: Stratified analysis by chemotherapy and herbal medicine use

Woo M, Lee J, Hyun M, Lee S, Medicine (Baltimore), 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at the medical records of adults with cancer who had hyperbaric oxygen therapy at one hospital in Korea, to check blood-related safety, including in people who also had chemotherapy or traditional Korean herbal therapy.

What They Found

This retrospective study of 259 adults with cancer who had 2692 low-pressure HBOT sessions found only 2 mild treatment-emergent adverse events (0.07%) and no serious or life-threatening events. Among 207 patients with paired laboratory results, most blood and biochemical measures were stable. Platelet count fell modestly (16 x 10^3 per microlitre, adjusted p less than 0.001) and plateletcrit fell by 0.01% (p less than 0.001), but average values stayed within reference ranges. In adjusted models, chemotherapy was linked to lower white blood cell and neutrophil counts, and herbal therapy to a minor drop in eosinophils. Neither was linked to platelet changes, and subgroup comparisons showed no clinically meaningful blood differences between exposed and unexposed groups.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective review of records from a single center with no randomized comparison group, so it cannot show that HBOT caused or prevented any change, and the authors say long-term safety still needs to be confirmed.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Uncategorised
Source Pubmed
PubMed ID 41088600
Year Published 2025
Journal Medicine (Baltimore)
MeSH Terms Humans; Hyperbaric Oxygenation; Female; Male; Retrospective Studies; Middle Aged; Neoplasms; Aged; Adult; Antineoplastic Agents; Phytotherapy; Platelet Count; Medicine, Korean Traditional

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology